Skip to main content
. 2024 May 2;16(5):e59533. doi: 10.7759/cureus.59533

Table 3. Side effects analysis among both groups.

Side effect Methocarbamol group (no. 55) Nefopam group (no. 55) P-value
Nausea 1 (1.8%) 2 (3.6%) 0.628
Vomiting 0 (0.0%) 1 (1.8%) 0.315
Tachycardia 5 (9.09%) 12 (21.81%) 0.003